Prevalence of hepatitis G virus infection in kidney transplant recipients

被引:12
作者
Dussol, B
Charrel, R
DeLamballerie, X
Berthezene, P
Brunet, P
DeMicco, P
Raoult, D
Berland, Y
机构
[1] HOP ST MARGUERITE, SERV NEPHROL & HEMODIALYSE, F-13009 MARSEILLE, FRANCE
[2] HOP ENFANTS LA TIMONE, VIROL LAB, MARSEILLE, FRANCE
[3] FAC MED, VIROL LAB, MARSEILLE, FRANCE
[4] INSERM U315, MARSEILLE, FRANCE
关键词
D O I
10.1097/00007890-199708150-00029
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. We investigated the prevalence, risk factors, and consequences of hepatitis G virus (HGV) infection in 87 kidney transplant recipients. Methods. Infection was diagnosed with reverse transcriptase polymerase chain reaction using primers in the NS3 region of the viral genoma. Results. Twenty-four patients (27.5%) were HGV RNA positive (HGV+ group) and 63 patients (72.5%) were HGV RNA negative (HGV- group). No statistically significant differences were found between the two groups for age, sex, transplantation and hemodialysis duration, number of kidney transplantations, serum creatinine, history of transfusions, hepatitis B and C virus infections, and percentage of patients having suffered from acute rejection. Acute and chronic hepatitis were not more prevalent in the HGV+ group than in the HGV- group. Conclusions. HGV infection is highly prevalent in kidney transplant recipients but does not alter liver or kidney functions. HGV contamination may be linked to nosocomial transmission during long-term hemodialysis.
引用
收藏
页码:537 / 539
页数:3
相关论文
共 13 条
[1]   NON-A, NON-B-HEPATITIS UNRELATED TO THE HEPATITIS-C VIRUS (NON-ABC) [J].
ALTER, HJ ;
BRADLEY, DW .
SEMINARS IN LIVER DISEASE, 1995, 15 (01) :110-120
[2]   The cloning and clinical implications of HGV and HGBV-C [J].
Alter, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (23) :1536-1537
[3]  
BELLI LS, 1996, LANCET, V335, P1394
[4]   Hepatitis GB virus C in patients on hemodialysis [J].
deLamballerie, X ;
Charrel, RN ;
Dussol, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (23) :1549-1549
[5]   Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent [J].
Linnen, J ;
Wages, J ;
ZhangKeck, ZY ;
Fry, KE ;
Krawczynski, KZ ;
Alter, H ;
Koonin, E ;
Gallagher, M ;
Alter, M ;
Hadziyannis, S ;
Karayiannis, P ;
Fung, K ;
Nakatsuji, Y ;
Shih, JWK ;
Young, L ;
Piatak, M ;
Hoover, C ;
Fernandez, J ;
Chen, S ;
Zou, JC ;
Morris, T ;
Hyams, KC ;
Ismay, S ;
Lifson, JD ;
Hess, G ;
Foung, SKH ;
Thomas, H ;
Bradley, D ;
Margolis, H ;
Kim, JP .
SCIENCE, 1996, 271 (5248) :505-508
[6]   Infection with hepatitis GB virus C in patients on maintenance hemodialysis [J].
Masuko, K ;
Mitsui, T ;
Iwano, K ;
Yamazaki, C ;
Okuda, K ;
Meguro, T ;
Murayama, N ;
Inoue, T ;
Tsuda, F ;
Okamoto, H ;
Miyakawa, Y ;
Mayumi, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (23) :1485-1490
[7]   Hepatitis G virus in long-term survivors of haematological malignancy [J].
Neilson, J ;
Harrison, P ;
Milligan, DW ;
Skidmore, SJ ;
Collingham, KE .
LANCET, 1996, 347 (9015) :1632-1633
[8]   ISOLATION OF NOVEL VIRUS-LIKE SEQUENCES ASSOCIATED WITH HUMAN HEPATITIS [J].
SIMONS, JN ;
LEARY, TP ;
DAWSON, GJ ;
PILOTMATIAS, TJ ;
MUERHOFF, AS ;
SCHLAUDER, GG ;
DESAI, SM ;
MUSHAHWAR, IK .
NATURE MEDICINE, 1995, 1 (06) :564-569
[9]  
Tsuda F, 1996, J MED VIROL, V49, P248, DOI 10.1002/(SICI)1096-9071(199607)49:3&lt
[10]  
248::AID-JMV15&gt